Noonberg Sarah B.
CIK: 0001706301•Chief Medical Officer
OfficerDirector
Primary company: Protagonist Therapeutics, Inc (PTGX)
Noonberg Sarah B. is a corporate insider (Chief Medical Officer) at Protagonist Therapeutics, Inc (PTGX) filing SEC Form 4 transactions. 34 transactions across 5 companies, totaling $0 in purchases and $221,723 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
Neurogene Inc. NGNE | Award | 12,050 | - | - | 12,050 | 6/12/2025 Filed: 6/13/2025 | Filing → |
| Sale | 5,239 | $1.75 | $9K | 109,135 | 6/6/2025 Filed: 6/9/2025 | Filing → | |
| Award | 84,000 | - | - | 84,000 | 4/1/2025 Filed: 4/3/2025 | Filing → | |
| Award | 14,000 | - | - | 114,374 | 4/1/2025 Filed: 4/3/2025 | Filing → | |
MARINUS PHARMACEUTICALS, INC. MRNS | Award | 10,450 | - | - | 10,450 | 6/18/2024 Filed: 6/20/2024 | Filing → |
MARINUS PHARMACEUTICALS, INC. MRNS | Award | 2,300 | - | - | 14,100 | 6/18/2024 Filed: 6/20/2024 | Filing → |
Neurogene Inc. NGNE | Award | 7,700 | - | - | 7,700 | 6/14/2024 Filed: 6/17/2024 | Filing → |
| Award | 242,875 | - | - | 242,875 | 4/1/2024 Filed: 4/3/2024 | Filing → | |
| Award | 57,763 | - | - | 100,374 | 4/1/2024 Filed: 4/3/2024 | Filing → | |
MARINUS PHARMACEUTICALS, INC. MRNS | Award | 20,900 | - | - | 20,900 | 1/18/2024 Filed: 1/19/2024 | Filing → |
MARINUS PHARMACEUTICALS, INC. MRNS | Award | 4,600 | - | - | 11,800 | 1/18/2024 Filed: 1/19/2024 | Filing → |
Neurogene Inc. NGNE | Award | 15,400 | - | - | 15,400 | 1/16/2024 Filed: 1/18/2024 | Filing → |
Neoleukin Therapeutics, Inc. NLTX | Award | 25,000 | $0.00 | $0 | 25,000 | 6/8/2023 Filed: 6/9/2023 | Filing → |
MARINUS PHARMACEUTICALS, INC. MRNS | Award | 32,400 | $0.00 | $0 | 32,400 | 5/16/2023 Filed: 5/17/2023 | Filing → |
MARINUS PHARMACEUTICALS, INC. MRNS | Award | 7,200 | $0.00 | $0 | 7,200 | 5/16/2023 Filed: 5/17/2023 | Filing → |
| Award | 30,000 | $0.00 | $0 | 30,000 | 1/16/2023 Filed: 1/18/2023 | Filing → | |
| Award | 20,000 | $0.00 | $0 | 20,000 | 5/26/2022 Filed: 5/27/2022 | Filing → | |
Neoleukin Therapeutics, Inc. NLTX | Award | 25,000 | $0.00 | $0 | 25,000 | 5/12/2022 Filed: 5/16/2022 | Filing → |
| Award | 18,000 | $0.00 | $0 | 18,000 | 5/27/2021 Filed: 5/28/2021 | Filing → | |
Neoleukin Therapeutics, Inc. NLTX | Award | 25,000 | $0.00 | $0 | 25,000 | 5/11/2021 Filed: 5/13/2021 | Filing → |
Neurogene Inc.
NGNE
Type
Award
Shares
12,050
Price
-
Value
-
Type
Sale
Shares
5,239
Price
$1.75
Value
$9K
Type
Award
Shares
84,000
Price
-
Value
-
Type
Award
Shares
14,000
Price
-
Value
-
MARINUS PHARMACEUTICALS, INC.
MRNS
Type
Award
Shares
10,450
Price
-
Value
-
MARINUS PHARMACEUTICALS, INC.
MRNS
Type
Award
Shares
2,300
Price
-
Value
-
Neurogene Inc.
NGNE
Type
Award
Shares
7,700
Price
-
Value
-
Type
Award
Shares
242,875
Price
-
Value
-
Type
Award
Shares
57,763
Price
-
Value
-
MARINUS PHARMACEUTICALS, INC.
MRNS
Type
Award
Shares
20,900
Price
-
Value
-
MARINUS PHARMACEUTICALS, INC.
MRNS
Type
Award
Shares
4,600
Price
-
Value
-
Neurogene Inc.
NGNE
Type
Award
Shares
15,400
Price
-
Value
-
Neoleukin Therapeutics, Inc.
NLTX
Type
Award
Shares
25,000
Price
$0.00
Value
$0
MARINUS PHARMACEUTICALS, INC.
MRNS
Type
Award
Shares
32,400
Price
$0.00
Value
$0
MARINUS PHARMACEUTICALS, INC.
MRNS
Type
Award
Shares
7,200
Price
$0.00
Value
$0
Type
Award
Shares
30,000
Price
$0.00
Value
$0
Type
Award
Shares
20,000
Price
$0.00
Value
$0
Neoleukin Therapeutics, Inc.
NLTX
Type
Award
Shares
25,000
Price
$0.00
Value
$0
Type
Award
Shares
18,000
Price
$0.00
Value
$0
Neoleukin Therapeutics, Inc.
NLTX
Type
Award
Shares
25,000
Price
$0.00
Value
$0
AI Agent
Try asking...